Overview

Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease

Status:
Unknown status

Trial end date:
2017-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the genetic variants of clock and narcolepsy genes that determine the therapeutic effects of Stalevo® on the quality of sleep in patients with Parkinson's Disease.

Phase:

N/A

Details

Lead Sponsor:

Asan Medical Center

Treatments:

Carbidopa
Entacapone
Levodopa